USSTOCK.TODAY
Market Closed
Log in Sign up

TriSalus Life Sciences Reports $12.9 Million in Q3 Revenue and Revises Annual Guidance

Nasdaq +2 · ·by G4L

TLSI
TLSI TriSalus Life Sciences Inc
$2.85 -11.49%
View chart & analysis →
  1. 1TriSalus Life Sciences recorded an 11.3% year-over-year revenue growth in Q3 2026.
  2. 2TriSalus Life Sciences achieved a Q3 2026 gross margin of 86.2%.
  3. 3TriSalus Life Sciences revised its full-year 2026 revenue guidance range to $46 million to $48 million.

So what's the key point?

TriSalus Life Sciences reported Q3 revenue of $12.9 million. The company updated its full-year revenue forecast to be between $46 million and $48 million.

Source Nasdaq +2 · View original ↗

Related 3-line summaries

Scale-up Gap for European Startups and Concentration on the US Market Klement on Investing · 2h agoRocket Lab expands backlog with $268 million in Q3 revenue Seeking Alpha +3 · 8h agoD-Wave Quantum Beats Q3 Revenue and EPS Estimates Nasdaq +3 · 9h ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news